Kinarus Therapeutics Holding AG in Liquidation and Curatis A

Kinarus Therapeutics Holding AG / Key word(s): Acquisition/Capital Increase29-Jan-2024 / 07:10 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR Application has been made to the courts of B...

Related Keywords

United Kingdom , China , Switzerland , Liestal , Basel Landschaft , France , Italy , Graubach , Sachsen Anhalt , Germany , United States , Basel Stadt , Chinese , Swiss , Marian Borovsky , Silvio Inderbitzin , Alexander Bausch , Spirig Pharma , Thomas Bieri , Roland Rutschmann , Kinarus Therapeutics Holding Ag Key , Kinarus Group , Kinarus Therapeutic Holding , Development Business For , Board Of Directors Kinarus Holding , Board Member Of Kinarus Holding , Meeting Of Kinarus Holding , Current Kinarus Holding , Liquidation Kinarus Holding , Kinarus Therapeutics Holding , Swiss Exchange , Kinarus Holding , Curatis Holding , Combination Transaction , Extraordinary General Meeting , Mandatory Exchangeable Loan Note , Group General Counsel , Transaction Agreement , Curatis Shares , Consideration Shares , New Kinarus Shares , Reserve Share Split , New Kinarus Share , Reverse Share Split , Kinarus Shares , Reverse Share , Board Member , Financing Transaction , Financing Round , Principal Amount , Orphan Diseases , Specialty Diseases Medicines , Specialty Indications , Rare Pediatric Disease Priority Review Voucher , Both Kinarus Therapeutics Holding , Executive Chairman , Directors Kinarus Therapeutics Holding , Technical Implementation Agent , Reverse Share Split Transaction ,